Observational studyJournal of neurology2023

Natalizumab continuation versus switching to ocrelizumab after PML risk stratification in RRMS patients: a natural experiment.

Albert Muñoz-Vendrell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.